Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results ...
The Arizona Diamondbacks have announced a multi-year agreement with Progressive Insurance as the team’s presenting sponsor of Diamondbacks Baseball Network, which includes game broadcasts through ...
10h
Zacks Investment Research on MSNProgressive (PGR) Ascends While Market Falls: Some Facts to NoteProgressive (PGR) closed the most recent trading day at $274.67, moving +0.78% from the previous trading session. This change outpaced the S&P 500's 0.33% loss on the day. Elsewhere, the Dow lost 0.37 ...
15h
Zacks Investment Research on MSNIs Progressive (PGR) a Solid Growth Stock? 3 Reasons to Think "Yes"Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth ...
Slideshows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results